Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Bladder Neoplasm+13.3Malignant Vaginal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Ovarian Neoplasm+6.7Malignant Pancreatic Neoplasm+6.7Malignant Salivary Gland Neop…+3.3Malignant Gastric Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Prostate Neoplasm+3.3Malignant Esophageal Neoplasm0Malignant Kidney Neoplasm0Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
48962
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2591599

2=Cutaneous Melanoma+2096.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7215
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2591600

3=Malignant Laryngeal Neoplasm+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3815
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2591601

4=Malignant Bladder Neoplasm+13.390Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11910
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
60
activityPercentile
46.7

ranking row 2591602

5=Malignant Vaginal Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
403
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2591603

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
762
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2591604

7=Malignant Ovarian Neoplasm+6.780Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13627
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
76.7
activityPercentile
70

ranking row 2591606

7=Malignant Pancreatic Neoplasm+6.780Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
29081
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
86.7
activityPercentile
80

ranking row 2591605

9=Malignant Salivary Gland Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
656
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2591607

10=Malignant Gastric Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12711
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
70
activityPercentile
66.7

ranking row 2591609

10=Malignant Mesothelioma+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2343
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2591608

10=Malignant Prostate Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
31728
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
90
activityPercentile
86.7

ranking row 2591610

13=Malignant Esophageal Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11917
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
63.3
activityPercentile
63.3

ranking row 2591611

13=Malignant Kidney Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11116
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
56.7
activityPercentile
56.7

ranking row 2591613

13=Malignant Lung Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
152061
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2591612

13=Malignant Rectal Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8260
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2591614

17=Malignant Hypopharyngeal Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
385
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
6.7
activityPercentile
10

ranking row 2591615

18=Malignant Testicular Neoplasm-3.443.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
378
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
3.3
activityPercentile
6.7

ranking row 2591616

19=Malignant Breast Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41528
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2591617

19=Malignant Central Nervous System Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12765
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2591618

21=Malignant Thyroid Gland Neoplasm-6.633.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1241
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
26.7
activityPercentile
33.3

ranking row 2591619

22=Malignant Penile Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
202
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2591620

23=Hodgkin Lymphoma-6.726.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1403
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
30
activityPercentile
36.7

ranking row 2591621

24=Leukemia-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21071
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2591622

24=Malignant Anal Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
462
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
13.3
activityPercentile
23.3

ranking row 2591624

24=Non-Hodgkin Lymphoma-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22802
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
83.3
activityPercentile
93.3

ranking row 2591623

27=Malignant Liver Neoplasm-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12382
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
66.7
activityPercentile
83.3

ranking row 2591625

27=Malignant Uterine Corpus Neoplasm-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3121
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2591626

29=Malignant Cervical Neoplasm-16.76.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4204
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2591627

30=Multiple Myeloma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10508
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2591628

31=Malignant Nasopharyngeal Neoplasm-26.60Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
638
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16.7
activityPercentile
43.3

ranking row 2591629

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 95c073bb22fbdd5ba2aa08d1